Evidence map›Paper›PMID 28343239›Full record

ArticleImmunogenetics2017

Improved full-length killer cell immunoglobulin-like receptor transcript discovery in Mauritian cynomolgus macaques.

Trent M Prall, Michael E Graham, Julie A Karl, Roger W Wiseman, Adam J Ericsen, Muthuswamy Raveendran, R Alan Harris, Donna M Muzny, Richard A Gibbs, Jeffrey Rogers and 1 more

Abstract read
In one paragraph

Article in Immunogenetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Trent M PrallWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53711, USA.
Michael E GrahamDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, 53711, USA.
Julie A KarlDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, 53711, USA.
Roger W WisemanWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53711, USA.
Adam J EricsenWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53711, USA.
Muthuswamy RaveendranHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
R Alan HarrisHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Donna M MuznyHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Richard A GibbsHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Jeffrey RogersHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
David H O'ConnorWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53711, USA. doconnor@primate.wisc.edu.
University of Wisconsin–Madison · USBaylor College of Medicine · USBaylor Genetics · US

Funding

GBV-C-mediated protection from AIDS in humans and GBV-C/SIV co-infected macaquesR01AI116382 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI O'CONNOR, DAVID H. · 2015 to 2018
$6.5M
EXTRAMURAL RES FACIL CONST: REPRODUCTIVE, GROWTH &DVMT, MENOPAUSEC06RR020141 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2004 to 2004
$3.6M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
EXTRAMURAL REGIONAL FACILITIES CONSTRUCTIONC06RR015459 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2000 to 2000
$1.9M
NCRR NIH HHS C06 RR015459NCRR NIH HHS C06 RR020141NIAID NIH HHS R01 AI116382NIAID NIH HHS T32 AI078985
6 · The paper itself

Abstract

Killer cell immunoglobulin-like receptors (KIRs) modulate disease progression of pathogens including HIV, malaria, and hepatitis C. Cynomolgus and rhesus macaques are widely used as nonhuman primate models to study human pathogens, and so, considerable effort has been put into characterizing their KIR genetics. However, previous studies have relied on cDNA cloning and Sanger sequencing that lack the throughput of current sequencing platforms. In this study, we present a high throughput, full-length allele discovery method utilizing Pacific Biosciences circular consensus sequencing (CCS). We also describe a new approach to Macaque Exome Sequencing (MES) and the development of the Rhexome1.0, an adapted target capture reagent that includes macaque-specific capture probe sets. By using sequence reads generated by whole genome sequencing (WGS) and MES to inform primer design, we were able to increase the sensitivity of KIR allele discovery. We demonstrate this increased sensitivity by defining nine novel alleles within a cohort of Mauritian cynomolgus macaques (MCM), a geographically isolated population with restricted KIR genetics that was thought to be completely characterized. Finally, we describe an approach to genotyping KIRs directly from sequence reads generated using WGS/MES reads. The findings presented here expand our understanding of KIR genetics in MCM by associating new genes with all eight KIR haplotypes and demonstrating the existence of at least one KIR3DS gene associated with every haplotype.

Indexed as

ExomeAnimalsGene FrequencyHigh-Throughput Nucleotide SequencingMacaca fascicularisReceptors, KIRSequence Analysis, DNAReceptors, KIRKiller cell immunoglobulin-like receptorsMauritian cynomolgus macaquesPacBio long-amplicon sequencingWhole Genome and Macaque Exome Sequencing

Identifiers

PMID28343239
PMCPMC5856007
OpenAlexW2949881706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.